Resveratrol Improves Endothelial Progenitor Cell Function through miR-138 by Targeting Focal Adhesion Kinase (FAK) and Promotes Thrombus Resolution In Vivo.

MLA

Zhang, Yeqing, et al. “Resveratrol Improves Endothelial Progenitor Cell Function through MiR-138 by Targeting Focal Adhesion Kinase (FAK) and Promotes Thrombus Resolution In Vivo.” Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, vol. 24, Feb. 2018, pp. 951–60. EBSCOhost, https://doi.org/10.12659/msm.906116.

APA

Zhang, Y., Du, X., Li, W., Sang, H., Qian, A., Sun, L., Li, X., & Li, C. (2018). Resveratrol Improves Endothelial Progenitor Cell Function through miR-138 by Targeting Focal Adhesion Kinase (FAK) and Promotes Thrombus Resolution In Vivo. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research, 24, 951–960. https://doi.org/10.12659/msm.906116

Chicago

Zhang, Yeqing, Xiaolong Du, Wendong Li, Hongfei Sang, Aimin Qian, Lili Sun, Xiaoqiang Li, and Chenglong Li. 2018. “Resveratrol Improves Endothelial Progenitor Cell Function through MiR-138 by Targeting Focal Adhesion Kinase (FAK) and Promotes Thrombus Resolution In Vivo.” Medical Science Monitor : International Medical Journal of Experimental and Clinical Research 24 (February): 951–60. doi:10.12659/msm.906116.